The underivatized alkaloid mixture extracted from the bulbs of Chlidanthus fragrans Herb. was investigated by capillary GC/MS for the first time. Fifteen known Amaryllidaceae alkaloids of five structure types were identified. The main alkaloids were tazzetine (9, tazettine-type), chlidanthine (2, galanthamine-type), belladine (8, belladine-type) and lycorine (12, lycorine-type). The alkaloid extract from the bulbs showed promising human blood acetylcholinesterase (IC50 = 20.1 ± 2.9 μg/mL) and human plasma butyrylcholinesterase (IC50 = 136.8 ± 6.9 μg/mL) inhibitory activity.
GrunertC. (1970) Das grosse Blumenzwiebelbuch, VEB Deutscher Landwirtschaftsverlag, Berlin, GER, 56-57.
2.
BastidaJ., LavillaR., ViladomatF. (2006) Chemical and biological aspects of Narcissus alkaloids. In The Alkaloids, Vol. 63, CordellG.A. (Ed.). Elsevier Scientific: Amsterdam, NL, 87–179.
3.
BerkovS., BastidaJ., ViladomatF., CodinaC. (2008) Analysis of galanthamine-type alkaloids by capillary gas chromatography-mass spectrometry in plants. Phytochemical Analysis, 19, 285–293.
4.
HostettmannK., BorlozA., UrbainA., MarstonA. (2006) Natural product inhibitors of acetylcholinesterase. Current Organic Chemistry, 10, 825–847.
5.
CampbellW.E., NairJ.J., GammonD.W., BastidaJ., CodinaC., ViladomatF., SmithP.J., AlbrechtC.F. (1988) Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis. Planta Medica, 64, 91–93.
6.
SzlávikL., GyurisÁ, MinárovitsJ., ForgoP., MolnárJ., HohmannJ. (2004) Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Medica, 70, 871–873.
7.
ZupkóI., RéthyB., HohmannJ., MolnárJ., OcsovczkiI., FalakyG. (2009) Antitumor activity of alkaloids derived from Amaryllidaceae species. In Vivo, 23, 41–48.
8.
BoitH.G. (1956) Alkaloide von Chlidanthus fragrans, Vallota purpurea, Nerine undulata und Hippeastrum vittatum (XI. Mitteil. über Amaryllidaceen-Alkaloide). Chemische Berichte, 89, 1129–1134.
9.
NoqueirasC., DöpkeW., LehmannG. (1971) Zur Struktur eines neuen Alkaloids aus Chlidanthus fragrans. Tetrahedron Letters, 35, 3249–3250.
10.
RheeI.K., van de MeentM., IngkaninanK., VerpoorteR. (2001) Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. Journal of Chromatography A, 915, 217–223.
11.
LahiriD.K., FarlowM.R., GreigN.H., SambamurtiK. (2002) Current drug targets for Alzheimer's disease treatment. Drug Development Research, 56, 267–281.
12.
RahmanA.U., CoudharyM.I. (2001) Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure and Applied Chemistry, 73, 555–560.
13.
GreigN.H., LahiriD.K., SambamurtiK. (2002) Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics, 14, 77–91.
14.
LleóA. (2007) Current therapeutic options for Alzheimer's disease. Current Genomics, 8, 550–558.
15.
RecanatiniM., ValentiP. (2004) Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. Current Pharmaceutical Design, 10, 3157–3166.
BerkovS., BastidaJ., NikolovaM., ViladomatF., CodinaC. (2008) Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extract. Phytochemical Analysis, 19, 411–419.
26.
LópezS., BastidaJ., ViladomatF., CodinaC. (2002) Acetylcholinesterase inhibitory activity of same Amaryllidaceae alkaloids and Narcissus extracts. Life Sciences, 71, 2521–2529.
27.
SteckT.L., KantJ.A. (1974) Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods in Enzymology, 31(Pt A), 172–180.
28.
EllmanG.L., CourtneyK.D., AndresV., FeatherstoneR.M. (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88–95.
